Search

Home > Lung Cancer Considered > LAURA Trial Part 1
Podcast: Lung Cancer Considered
Episode:

LAURA Trial Part 1
Category: Science & Medicine
Duration: 00:27:05
Publish Date: 2024-11-29 00:00:00
Description: Lung Cancer Considered host Dr. Narjust Florez and Dr. Suresh Ramalingam discuss the recent FDA approval of osimertinib after chemo-radiation in EGFR positive NSCLC. The approval was based, in part, on the results of the LAURA trial, which was presented at the 2024 ASCO Annual Meeting. Guest: Dr. Suresh Ramalingam is the Executive Director, Winship Cancer Institute of Emory University, the Roberto C. Goizueta Distinguished Chair for Cancer Research, and a professor of medicine at Emory University School of Medicine. He is also the editor in chief for the Cancer Journal.
Total Play: 0